Alligator Bioscience AB (publ)

OM:ATORX Stock Report

Market Cap: kr693.6m

Alligator Bioscience Balance Sheet Health

Financial Health criteria checks 3/6

Alligator Bioscience has a total shareholder equity of SEK11.9M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK118.5M and SEK106.6M respectively.

Key information

0%

Debt to equity ratio

kr0

Debt

Interest coverage ration/a
Cashkr66.12m
Equitykr11.86m
Total liabilitieskr106.60m
Total assetskr118.45m

Recent financial health updates

Recent updates

Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

Dec 01
Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Dec 21
We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Jul 30
Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Jan 06
Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

Aug 18
Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

Apr 11
Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

Estimating The Intrinsic Value Of Alligator Bioscience AB (publ) (STO:ATORX)

Feb 17
Estimating The Intrinsic Value Of Alligator Bioscience AB (publ) (STO:ATORX)

Have Insiders Been Buying Alligator Bioscience AB (publ) (STO:ATORX) Shares?

Jan 13
Have Insiders Been Buying Alligator Bioscience AB (publ) (STO:ATORX) Shares?

Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

Dec 09
Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

Financial Position Analysis

Short Term Liabilities: ATORX's short term assets (SEK78.2M) do not cover its short term liabilities (SEK99.1M).

Long Term Liabilities: ATORX's short term assets (SEK78.2M) exceed its long term liabilities (SEK7.5M).


Debt to Equity History and Analysis

Debt Level: ATORX is debt free.

Reducing Debt: ATORX has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ATORX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ATORX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.5% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.